LONA LEONABIO INC
FollowCOM (common), issuer CIK 1620463
43 managers (45 13F filers) reported a position in LONA shares at 2026-06-30, 7,271,683 shares in all. 7 filers opened a position and 3 filers sold out during the quarter.
- Managers
- 43
- 13F filers
- 45
- New
- 7
- Added
- 8
- Reduced
- 7
- Sold out
- 3
- Shares held by filers
- 7,271,683
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- GREAT POINT PARTNERS LLC(group GREAT POINT PARTNERS LLC)
474,345 shares, 5.03% in a 13G as of 2026-10-28,0001172661-26-004856
Accepted , ingested - PERCEPTIVE ADVISORS LLC(group PERCEPTIVE ADVISORS LLC)
1,889,403 shares, 19.99% in a 13D/A as of 2026-10-26,0001193125-26-431897
Accepted , ingested - Sermonix Pharmaceuticals, Inc. (group Sermonix Pharmaceuticals, Inc.)
3,149,470 shares, 25.1% in a 13D/A as of 2026-10-26,0001655566-26-000004
Accepted , ingested - Spruce Street Capital LP(group Spruce Street Capital LP)
393,700 shares, 4.2% in a 13G as of 2026-09-30,0000902664-26-004525
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Portman David J.10% owner | 2026-10-26 | +3,149,470 P | $3,149.47 | Form 4 |
| PERCEPTIVE ADVISORS LLCdirector, 10% owner | 2026-10-26 | +776,648 M | $0.001 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Spruce Street Capital LP and 2 other reporting persons reported 393,700 LONA shares, 4.2% of the class, as of 2026-09-30, in a 13G filed 2026-11-13. 0000902664-26-004525
Accepted , ingestedGREAT POINT PARTNERS LLC and 2 other reporting persons reported 474,345 LONA shares, 5.03% of the class, as of 2026-10-28, in a 13G filed 2026-11-04. 0001172661-26-004856
Accepted , ingestedPortman David J. bought 3,149,470 LONA shares on 2026-10-26, Form 4 filed 2026-10-28. 0002126186-26-000002
Accepted , ingestedSermonix Pharmaceuticals, Inc. and 1 other reporting person reported 3,149,470 LONA shares, 25.1% of the class, as of 2026-10-26, in a 13D/A filed 2026-10-28. 0001655566-26-000004
Accepted , ingestedPERCEPTIVE ADVISORS LLC and 2 other reporting persons acquired 776,648 LONA shares on 2026-10-26, Form 4 filed 2026-10-26. 0001193125-26-431896
Accepted , ingestedPERCEPTIVE ADVISORS LLC and 3 other reporting persons reported 1,889,403 LONA shares, 19.99% of the class, as of 2026-10-26, in a 13D/A filed 2026-10-26. 0001193125-26-431897
Accepted , ingested